Wordt geladen...
mTOR signaling: new networks for ALL
Compared with rapamycin, mammalian target of rapamycin (mTOR) dual inhibitors have shown improved ability to kill acute lymphocytic leukemia (ALL) cells in preclinical models. In this issue of Blood, Yun et al have identified novel signaling pathways downstream of mTOR that are disrupted by dual inh...
Bewaard in:
| Gepubliceerd in: | Blood |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4891950/ https://ncbi.nlm.nih.gov/pubmed/27257176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-03-703199 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|